Showing results (21-30 of 154) with videos related to
Sort By:
Pageof 16
Blood Advances|January 4, 2018
Emerging role of BCR signaling inhibitors in immunomodulation of chronic lymphocytic leukemiaKamira Maharaj, Eva Sahakian, Javier Pinilla-IbarzCancer Genetics and Cytogenetics|March 11, 2008
A case of acute basophilic leukemia arising from chronic myelogenous leukemia with development of t(7;8)(q32;q13)Joseph Pidala, Javier Pinilla-Ibarz, Hernani D CualingCancer|October 6, 2010
Intolerance to tyrosine kinase inhibitors in chronic myeloid leukemia: Definitions and clinical implicationsJavier Pinilla-Ibarz, Jorge Cortes, Michael J MauroCore Evidence|May 30, 2013
Ibrutinib: an evidence-based review of its potential in the treatment of advanced chronic lymphocytic leukemiaJulio C Chavez, Eva Sahakian, Javier Pinilla-IbarzExpert Opinion on Investigational Drugs|May 31, 2021
Galinpepimut-S (GPS): an investigational agent for the treatment of acute myeloid leukemiaAkriti Gupta Jain, Chetasi Talati, Javier Pinilla-IbarzCancer Control : Journal of the Moffitt Cancer Center|April 2, 2009
The biological basis for immunotherapy in patients with chronic myelogenous leukemiaJavier Pinilla-Ibarz, Bijal Shah, Jason A DubovskyFrontiers in Immunology|August 18, 2022
Regulatory T cells (Tregs) in lymphoid malignancies and the impact of novel therapiesKamira Maharaj, Angimar Uriepero, Eva Sahakian, et al.Cancer Control : Journal of the Moffitt Cancer Center|December 7, 2011
Immunomodulatory drugs and active immunotherapy for chronic lymphocytic leukemiaEstrella Carballido, Marays Veliz, Rami Komrokji, et al.Anticancer Research|December 6, 2015
Long-term BCR-ABL1 Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid LeukemiaJavier Pinilla-Ibarz, Kendra Sweet, Josephine Emole, et al.Critical Reviews in Oncology/Hematology|August 24, 2013
The one-two punch: combination treatment in chronic myeloid leukemiaKendra L Sweet, Lori A Hazlehurst, Javier Pinilla-IbarzPageof 16